Scalco Elisa, Marzi Simona, Sanguineti Giuseppe, Vidiri Antonello, Rizzo Giovanna
Institute of Molecular Bioimaging and Physiology (IBFM), CNR, Segrate (MI), Italy.
Medical Physics Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
Phys Med. 2016 Dec;32(12):1672-1680. doi: 10.1016/j.ejmp.2016.09.003. Epub 2016 Sep 14.
In the treatment of Head-and-Neck Squamous Cell Carcinoma (HNSCC), the early prediction of residual malignant lymph nodes (LNs) is currently required. Here, we investigated the potential of a multi-modal characterization (combination of CT, T2w-MRI and DW-MRI) at baseline and at mid-treatment, based on texture analysis (TA), for the early prediction of LNs response to chemo-radiotherapy (CRT).
30 patients with pathologically confirmed HNSCC treated with CRT were considered. All patients underwent a planning CT and two serial MR examinations (including T2w and DW images), one before and one at mid-CRT. For each patient the largest malignant LN was selected and within each LN, morphological and textural features were estimated from T2w-MRI and CT, besides a quantification of the apparent diffusion coefficient (ADC) from DW-MRI. After a median follow-up time of 26.6months, 19 LNs showed regional control, while 11 LNs showedregional failure at a median time of 4.6months. Linear discriminant analysis was used to test the accuracy of the image-based features in predicting the final response.
Pre-treatment features showed higher predictive power than mid-CRT features, the ADC having the highest accuracy (80%); CT-based indices were found not predictive. When ADC was combined with TA, the classification performance increased (accuracy=82.8%). If only T2w-MRI features were considered, the best combination of pre-CRT indices and their variation reached an equivalent accuracy (81.8%).
Our results may suggest that TA on T2w-MRI and ADC can be combined together to obtain a more accurate prediction of response to CRT.
在头颈部鳞状细胞癌(HNSCC)的治疗中,目前需要对残留恶性淋巴结(LN)进行早期预测。在此,我们基于纹理分析(TA),研究了在基线期和治疗中期进行多模态特征描述(CT、T2加权磁共振成像(T2w-MRI)和扩散加权磁共振成像(DW-MRI)的组合)对LN对放化疗(CRT)反应的早期预测潜力。
纳入30例经病理证实接受CRT治疗的HNSCC患者。所有患者均接受了一次计划CT和两次系列磁共振检查(包括T2w和DW图像),一次在CRT前,一次在CRT中期。对于每位患者,选择最大的恶性LN,在每个LN内,除了从DW-MRI定量表观扩散系数(ADC)外,还从T2w-MRI和CT估计形态学和纹理特征。中位随访时间为26.6个月后,19个LN显示区域控制,而11个LN在中位时间4.6个月时显示区域失败。使用线性判别分析来测试基于图像的特征预测最终反应的准确性。
治疗前特征显示出比CRT中期特征更高的预测能力,ADC的准确性最高(80%);基于CT的指标未显示出预测性。当ADC与TA结合时,分类性能提高(准确性=82.8%)。如果仅考虑T2w-MRI特征,CRT前指标及其变化的最佳组合达到了同等的准确性(81.8%)。
我们的结果可能表明,T2w-MRI上的TA和ADC可以结合在一起,以获得对CRT反应更准确的预测。